Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 3, 2026

Feb. 3, 2026

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy Results in Sustained, Significant Reductions in CSF-HS and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in…

GlobeNewswire

Feb. 3, 2026

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire

Feb. 3, 2026

Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire

Feb. 3, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 3, 2026

In response to private lab closure in Sudbury, experts call on the province to transfer the service back to local public hospitals

GlobeNewswire

Feb. 3, 2026

BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)

GlobeNewswire

Feb. 3, 2026

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

Feb. 3, 2026

Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments

GlobeNewswire

Feb. 3, 2026

Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026

GlobeNewswire

Feb. 3, 2026

TSC Life Receives FDA Clearance for Pediatric Use with Fluido® Compact System, a Blood & Fluid Warmer, in the U.S. and Canada

GlobeNewswire

Feb. 3, 2026

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

GlobeNewswire

Feb. 3, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

Feb. 3, 2026

Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

GlobeNewswire

Feb. 3, 2026

Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

GlobeNewswire

Feb. 3, 2026

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

GlobeNewswire

Feb. 3, 2026

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

GlobeNewswire

Feb. 3, 2026

X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

GlobeNewswire

Feb. 3, 2026

Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

GlobeNewswire

Feb. 3, 2026

Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire

Feb. 3, 2026

Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced

GlobeNewswire